Grifols and Talecris Sign Consent Agreement with FTC
![]() |
(Research Triangle Park, N.C.) Grifols, S.A. (GRF.MC) and Talecris Biotherapeutics Holdings Corp. (NASDAQ: TLCR) announced today they have signed a Consent Agreement with the staff of the Bureau of Competition of the U.S. Federal Trade Commission (FTC) that outlines the conditions necessary for Grifols’ acquisition of Talecris to proceed. The Consent Agreement remains subject to approval by the FTC Commissioners before the transaction can be completed. (more…)

